U.S. Transportation Stock News

MannKind Corporation recently reported Q1 2026 revenues of US$90.2 million, a 15% year-on-year increase driven mainly by Furoscix net sales and Tyvaso DPI royalties, alongside an expanded collaboration with United Therapeutics that includes a US$5 million payment to accelerate Ralinepag DPI development. With key upcoming FDA action dates for Afrezza’s pediatric indication and the Furoscix ReadyFlow Autoinjector, MannKind’s revenue mix and partnership profile are becoming more closely tied to...

Watts Water Technologies (WTS) is back in focus after recent analyst upgrades and a Q1 earnings beat highlighted solid organic sales growth, stronger data center demand, and better free cash flow margins. See our latest analysis for Watts Water Technologies. Despite the recent Q1 beat and M&A commentary, short term momentum has been mixed, with a 1 day share price return of 1.04% but a 90 day share price return down 9.16%, while the 1 year total shareholder return of 26.62% and 5 year total...

Gaming and Leisure Properties, Inc. previously announced that its Board approved a second-quarter 2026 cash dividend of US$0.82 per share, a 5% increase from the prior payout, payable on June 26, 2026 to shareholders of record on June 12, 2026. This higher dividend underscores the REIT’s emphasis on consistent cash distributions backed by recurring triple-net lease income from its gaming real estate portfolio. With this 5% dividend increase now in place, we’ll examine how a richer cash...

In recent announcements, American Water Works’ subsidiaries outlined extensive 2026 infrastructure programs, including roughly US$277,000,000 in California, US$290,000,000 in Illinois, over US$40,000,000 in Tennessee, and about US$17,800,000 for Pennsylvania storage tanks, alongside completing a US$4,000,000 main replacement in Bellflower, California. Together with a new US$500,000,000 senior notes issue, these projects highlight the company’s heavy capital commitment to modernizing...

Array Technologies recently reported a surprise Q1 2026 profit with adjusted EPS of US$0.06, beat revenue expectations, and ended the quarter with a record US$2.40 billion order book while forecasting strong revenue and EBITDA growth for the rest of the year. A new role as tracker supplier for Statkraft’s high‑altitude Lupi solar project in Peru underscores Array’s growing international footprint and ability to deploy its technology in demanding environments. With that backdrop of a surprise...

In May 2026, Acuity Inc. entered into a new unsecured revolving credit agreement led by JPMorgan Chase, replacing its 2022 facility and providing up to $800 million of availability maturing in May 2031, subject to leverage-based covenants and customary restrictions. This long-dated, flexible borrowing capacity, tied to Acuity’s leverage ratio or credit rating, gives the company additional financial room to support operations, acquisitions, and ongoing capital allocation choices. Next, we’ll...

In the past quarter, Nu Holdings Ltd. reported record first‑quarter 2026 results, with net income rising to US$872.06 million and basic earnings per share from continuing operations increasing to US$0.1796, alongside strong customer growth past 135 million and robust revenue expansion across Latin America. Despite this operational strength, the company’s slight earnings-per-share miss versus consensus and higher credit provisions in a tougher Latin American backdrop have raised fresh...

Pentair recently drew renewed attention after hitting a yearly trading low, even as it continues to report resilient operational performance in water treatment, filtration, and fluid management across residential, commercial, and industrial markets. This combination of operational resilience, cautious management commentary, and growing interest in long-cycle water infrastructure has sharpened investor focus on Pentair’s fundamentals and long-term role in global water systems. With investor...

In early May 2026, GATX Corporation reported first-quarter 2026 results showing higher year-over-year sales of US$518.7 million and revenue of US$583.7 million, alongside net income of US$85.5 million and diluted earnings per share from continuing operations of US$2.35, while reiterating full-year 2026 earnings guidance of US$9.50 to US$10.10 per diluted share. A few days later, GATX filed a US$237.93 million shelf registration for 1,300,000 common shares tied to an ESOP-related offering,...

What Ecolab’s new bond offerings mean for equity investors Ecolab (ECL) has just tapped the bond market with several fixed rate note offerings totaling multiple billions of US dollars, across maturities from 2029 to 2036, drawing fresh attention to the stock. The company issued callable, senior unsecured notes with fixed coupons, including 4.600% notes due 2029, 4.800% notes due 2031, 5.150% notes due 2033, and 5.350% notes due 2036, each priced slightly below par. See our latest analysis for...

Preferred Bank recently announced it had reached a settlement to recover US$5.7 million over eleven months on a commercial and industrial loan that was previously charged off in the second quarter of 2024, and reported first-quarter 2026 earnings per share of US$2.53 with revenue coming in below forecasts. This combination of an unexpected cash recovery on a written-off loan and an earnings beat on per-share profit adds a fresh dimension to how investors may assess the bank's credit...

Syndax Pharmaceuticals (SNDX) is back in focus after highlighting 12 new Revuforj abstracts ahead of the European Hematology Association 2026 Congress, drawing attention to extensive clinical and real-world data across acute leukemia settings. See our latest analysis for Syndax Pharmaceuticals. The recent Revuforj data spotlight comes as Syndax’s share price sits at US$20.13, with a year to date share price return down 5.49% but a 1 year total shareholder return of 89.01%, suggesting longer...

In early May 2026, Privia Health Group reported first-quarter results showing sales rising to US$603.85 million from US$480.10 million a year earlier, while net income eased to US$3.06 million from US$4.22 million and diluted EPS held at US$0.02. At the same time, the company maintained its 2026 GAAP revenue outlook of US$2.35 billion to US$2.45 billion, indicating confidence in meeting full-year expectations despite slimmer quarterly profits. We’ll now examine how sustaining full-year...

Core & Main (CNM) has been drawing fresh attention as it reports wider free cash flow margins, continues share repurchases, and steps up visibility at water industry conferences in Kentucky, North Carolina, and New Jersey this May. See our latest analysis for Core & Main. At a share price of US$47.12, Core & Main has seen a 1-day share price return of 4.73%, although the share price is down 11.78% year to date and the 1-year total shareholder return is down 10.57%. The 3-year total...

Packaging Corporation of America (PKG) is back on investors’ radar after its recent share price move, with the stock now around $213.21 and showing mixed returns across the past week, month, and past 3 months. See our latest analysis for Packaging Corporation of America. The recent 1-day share price gain of 4.94% contrasts with a 90 day share price return that is down 10.77%, while the 1 year total shareholder return of 14.50% points to momentum that has been building over a longer...

Event driven focus on CRISPR Therapeutics stock CRISPR Therapeutics (CRSP) is back on investor radars after recent positive revisions to earnings projections and fresh updates on the commercial rollout of CASGEVY, including reimbursement progress in Germany and ongoing patient initiations. See our latest analysis for CRISPR Therapeutics. Despite the recent news flow, CRISPR Therapeutics’ share price is US$48.55 after a 1-day share price return of 2.02%. However, the 30-day share price return...

In the past few days, Tsakos Energy Navigation reported fourth-quarter 2025 results that materially exceeded earnings and revenue expectations, underscoring strong operational performance in its energy transportation business. This outperformance against analyst forecasts highlights the company’s ability to leverage its fleet and contracts more efficiently than the market had anticipated. We’ll now examine how this earnings beat, and what it suggests about Tsakos Energy Navigation’s...

In the past quarter, Howmet Aerospace Inc. reported Q1 2026 sales of US$2,313 million, net income of US$580 million, and fully diluted EPS of US$1.44, while also completing a multi‑year buyback program totaling 34,011,088 shares for US$2.45 billions since its 2021 authorization. The company’s decision on May 7, 2026 to raise full‑year 2026 revenue guidance to a baseline of US$9,650 million highlights management’s confidence in demand for its aerospace and turbine components. Next, we’ll...

Woodward stock snapshot after recent performance shifts Woodward (WWD) has drawn fresh attention after a mixed stretch in its share performance, with the stock up about 3.3% in the past day but down over the past week and month. See our latest analysis for Woodward. That 3.3% 1 day share price gain comes after share price returns that declined 9.5% over the past month, yet the 1 year total shareholder return of 72.2% and 3 year total shareholder return above 2x suggest longer term momentum...

CDW stock performance snapshot after recent moves CDW (CDW) has drawn investor attention after recent share price swings, with the stock up 1.8% over the past day and 5.8% over the past week, but down over the past month and past 3 months. At a last close of US$106.21 and a market value of about US$13.3b, the company sits against a backdrop of annual revenue of US$22.9b and net income of US$1.1b, representing a sizable footprint in IT solutions. See our latest analysis for CDW. While the...

Boston Scientific (BSX) reported that its SEISMIQ 4CE coronary intravascular lithotripsy catheter met all primary safety and effectiveness endpoints in the pivotal FRACTURE trial, supporting regulatory plans and drawing fresh attention to the stock. See our latest analysis for Boston Scientific. Despite the positive FRACTURE trial news and other recent updates such as the MiRus investment and a US$2b accelerated share repurchase, momentum has been weak. The share price is down 40.2% year to...

KE Holdings (BEKE) is back in the spotlight after reporting first quarter 2026 results that paired lower revenue and transaction volumes with higher net income, stronger margins, and continued share repurchases. See our latest analysis for KE Holdings. Despite the stronger Q1 profitability and ongoing buybacks, the stock has come under pressure in the very short term, with a 1 day share price return of 3.47% and a 7 day return of 7.76%. That follows a 30 day share price return of 9.91% and a...

Vita Coco Company stock snapshot Vita Coco Company (COCO) has drawn attention after a strong recent run, with the stock up 64.1% over the past month and 50.5% over the past 3 months. This performance is inviting closer scrutiny of its fundamentals. See our latest analysis for Vita Coco Company. At a share price of $77.88, Vita Coco’s recent surge reflects building momentum, with a 64.1% 1 month share price return and a 111.4% 1 year total shareholder return hinting at shifting growth and risk...

In May 2026, Vontier Corporation’s board increased its share repurchase authorization to US$1.00 billion and affirmed a quarterly dividend of US$0.025 per share payable on June 25, 2026, following an ex-dividend and record date of June 4, 2026. This larger buyback pool, alongside ongoing dividends, highlights management’s emphasis on capital returns at a time when investors are reassessing Vontier’s operating trends and cash allocation priorities. We’ll now examine how Vontier’s expanded...